Instem plc Director/PDMR Shareholding (1276D)
29 January 2018 - 6:00PM
UK Regulatory
TIDMINS
RNS Number : 1276D
Instem plc
29 January 2018
Instem plc
("Instem" or the "Company")
Instem plc (AIM: INS), a leading provider of IT solutions to the
global life sciences market, was notified on 25 January 2018, that
the DG 2008 Discretionary Settlement (of which David Gare (the
Company chairman) and his wife are the trustees) transferred 70,000
ordinary shares of 10p each in the Company ("Ordinary Shares") to
David's son Adrian Gare and a further 70,000 to his daughter,
Deborah Walker, for nil consideration. Following the transaction,
the DG 2008 Discretionary Settlement now has a total interest in
1,258,427 Ordinary Shares, representing 7.92% of the Company's
issued share capital.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging
managerial responsibilities / person
closely associated
---- ----------------------------------------------------------------
a) Name David Gare and his wife
(via the DG 2008 Discretionary
Settlement)
---- ------------------------- -------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------
a) Position/status Chairman of the Company
---- ------------------------- -------------------------------------
b) Initial notification Initial
/Amendment
---- ------------------------- -------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
---- ----------------------------------------------------------------
a) Name Instem plc
---- ------------------------- -------------------------------------
b) LEI 213800PILYUFNNROQX68
---- ------------------------- -------------------------------------
4 Details of the transaction(s): section
to be repeated for (i) each type of
instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place
where transactions have been conducted
---- ----------------------------------------------------------------
a) Description Ordinary shares of 10p
of the financial each
instrument,
type of instrument
----
Identification GB00B3TQCK30
code
b) Nature of Transfer of ordinary shares
the transaction
---- ------------------------- -------------------------------------
c) Price(s) and
volume(s)
---- --------------- -----------------
Price(s) Volume(s)
---- --------------- -----------------
0p 140,000
--------------- -----------------
d) Aggregated
information
----
- Aggregated N/A
volume
- Price
e) Date of the 25 January 2018
transaction
---- ------------------------- -------------------------------------
f) Place of the London Stock Exchange
transaction (XLON)
---- ------------------------- -------------------------------------
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated
Adviser & Broker) +44 (0) 20 7496 3000
Richard Lindley
James White
Walbrook Financial PR +44 (0) 20 7933 8780
Paul Cornelius instem@walbrookpr.com
Helen Cresswell
Sam Allen
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management and Data Collection; Regulatory Solutions for
Submissions and Compliance; and Informatics-based Insight
Generation.
Instem solutions are in use by customers worldwide and enable
our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United
States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please
visit instem.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBCGDBXUDBGII
(END) Dow Jones Newswires
January 29, 2018 02:00 ET (07:00 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Apr 2024 to May 2024
Instem (LSE:INS)
Historical Stock Chart
From May 2023 to May 2024